Interview with Guillaume Desachy and Nicole Krämer
Biomarkers help you in all kinds of different ways, so stay tuned while Guillaume, Nicole, and I talk about the following points:
- What are biomarkers for you?
- What makes it such an interesting topic?
- Why do you want to revitalize the biomarker SIG?
- What are your goals for the SIG?
- The richness of biomarkers requires more advanced methods. What would you foresee your SIG to do about these?
- How can people join the SIG?
Reference: SIGS Biomarkers
Please send an email to Nicole or Guillaume.
Listen to this episode and share this with your friends and colleagues!
Never miss an episode!
Join thousends of your peers and subscribe to get our latest updates by email!
Get the
Learn on demand
Click on the button to see our Teachble Inc. cources.
Featured courses
Click on the button to see our Teachble Inc. cources.
Guillaume Desachy
Since graduating from ENSAI (Biostatistics M. Sc.) 10 years ago, Guillaume has been immersing himself in precision medicine.
Data-driven, he is passionate about answering scientific questions and making sure we convey the right message to stakeholders, both internally & externally.
He feels very fortunate to have had the chance to work with various kinds of OMIC data and leverage the power of biomarkers to strengthen drug development.
He also feels incredibly lucky to have worked in a diverse set of settings, be it in academia (UCSF, U.S.), in a biotech (Enterome, France), or the pharmaceutical industry (BMS, Servier & AstraZeneca, France & Sweden). He now works as a Statistical Science Director for AstraZeneca in Gothenburg, Sweden.
Apart from his day job at AstraZeneca, Guillaume teaches a course about OMICs data analysis at ENSAI (www.ensai.fr), is a Board Member in the ENSAI alumni association (www.ensai.org), and is a mentor for Article 1, a non-profit organization promoting equal opportunity (https://article-1.eu/).
Whether it is to discuss statistics, choices that you are making in your early career, or any other subject, you can contact him via LinkedIn (https://www.linkedin.com/in/guillaume-desachy/).
Nicole Krämer
She received her PhD in machine learning in 2006. Together with Guillaume Desachy, she chairs the EFSPI/PSI Biomarker Special Interest Group. She is also a member of the EFSPI/PSI Subgroups Special Interest Group.
Nicole is a senior principal statistician at Boehringer Ingelheim in Biberach, Germany. As a member of the Therapeutic Area & Methodology Statistics Group, she supports clinical development teams in terms of strategy and methodology for biomarker analysis, translational topics, and early clinical development. Her interests include complex high-dimensional data, subgroup identification, and model validation.
Join The Effective Statistician LinkedIn group
This group was set up to help each other to become more effective statisticians. We’ll run challenges in this group, e.g. around writing abstracts for conferences or other projects. I’ll also post into this group further content.
I want to help the community of statisticians, data scientists, programmers and other quantitative scientists to be more influential, innovative, and effective. I believe that as a community we can help our research, our regulatory and payer systems, and ultimately physicians and patients take better decisions based on better evidence.
I work to achieve a future in which everyone can access the right evidence in the right format at the right time to make sound decisions.
When my kids are sick, I want to have good evidence to discuss with the physician about the different therapy choices.
When my mother is sick, I want her to understand the evidence and being able to understand it.
When I get sick, I want to find evidence that I can trust and that helps me to have meaningful discussions with my healthcare professionals.
I want to live in a world, where the media reports correctly about medical evidence and in which society distinguishes between fake evidence and real evidence.
Let’s work together to achieve this.
